Amneal Pharmaceuticals, Inc. (NASDAQ: AMRX)
$7.9900
+0.1400 ( -0.25% ) 367.0K
Amneal Pharmaceuticals Inc is a global pharmaceutical company operating primarily in the U.S., India, and Ireland. With three reportable segments; Generics, Specialty, and AvKARE - It develop, manufacture, and distribute a diverse portfolio of essential medicines. The Generics segment focuses on a wide range of dosage forms and delivery systems, contributing significantly to revenues. The Specialty segment promotes proprietary branded pharmaceuticals, particularly targeting the central nervous system and endocrine disorders. The AvKARE segment provides pharmaceuticals and medical products to governmental agencies, specializing in re-packaging and wholesale distribution, with a focus on offering consistent care and pricing to qualified entities.
Market Data
Open
$7.9900
Previous close
$7.8500
Volume
367.0K
Market cap
$2.47B
Day range
$7.5800 - $8.1000
52 week range
$5.0100 - $9.4750
SEC Filings
Form Type | Description | Pages | Date |
---|---|---|---|
4 | Insider transactions | 1 | Nov 26, 2024 |
4 | Insider transactions | 1 | Nov 25, 2024 |
4 | Insider transactions | 1 | Nov 22, 2024 |
4 | Insider transactions | 1 | Nov 19, 2024 |
8-k/a | 8K-related | 15 | Nov 12, 2024 |
10-q | Quarterly Reports | 103 | Nov 12, 2024 |
8-k | 8K-related | 3 | Nov 08, 2024 |
8-k | 8K-related | 17 | Oct 01, 2024 |
4 | Insider transactions | 1 | Aug 16, 2024 |
4 | Insider transactions | 1 | Aug 16, 2024 |